Story perspectives

Japan Greenlights Stem-Cell Therapies for Parkinson's, Heart Disease

3/9/2026

Summary

Story summary

Japan has approved stem-cell therapies for Parkinson's disease and heart failure, with treatments due within months.
Sumitomo Pharma won approval for Amchepry, a Parkinson's treatment transplanting stem cells into the brain.
Japan's health ministry also authorized ReHeart, heart muscle sheets from Cuorips aiding vessel formation.
Treatments could reach patients by summer 2026 via expedited conditional marketing.
A study showed safety and symptom improvement in some Parkinson's patients.

1 of 1

Story summary

Japan has approved stem-cell therapies for Parkinson's disease and heart failure, with treatments due within months.
Sumitomo Pharma won approval for Amchepry, a Parkinson's treatment transplanting stem cells into the brain.
Japan's health ministry also authorized ReHeart, heart muscle sheets from Cuorips aiding vessel formation.
Treatments could reach patients by summer 2026 via expedited conditional marketing.
A study showed safety and symptom improvement in some Parkinson's patients.